The Australian Government Chief Medical Officer, Professor Chris Baggoley, has established a Clinical Advisory Committee on Lyme disease to provide him with advice on the evidence for Lyme disease in Australia, diagnostic testing, treatment and research requirements. The Committee will also provide advice on the most appropriate ways to disseminate information to health professionals and the general public.
Clinical Advisory Committee on Lyme Disease
The purpose of the CACLD is to provide advice to the Chief Medical Officer on:
- the extent to which there is evidence of Borrelia spp causing illness in humans in Australia
- the most appropriate laboratory diagnostic testing algorithms (best world practice) for persons who have suspected borreliosis in Australia
- the most appropriate treatments for borreliosis in Australia
- the most appropriate ways to disseminate information to health professionals and the general public on borreliosis/Lyme disease
- the requirements for further research into borreliosis in Australia, and
- the generation of appropriate new questions relevant to the terms of reference.
The committee has representation from the following organisations:
- Australian Government Department of Health
- Karl McManus Foundation
- Lyme Disease Association of Australia
- Public Health Laboratory Network
- Communicable Diseases Network Australia
- NSW Health
- Royal College of Pathologists of Australasia
- Royal Australian College of General Practitioners
- National Health and Medical Research Council
- Australian Society for Infectious Diseases
- An Australian and International Expert
The Committee met on 19 March 2013 with the following outcomes:
- Suggested terms of reference for the Clinical Advisory Committee on Lyme disease to be re-drafted to incorporate members’ comments.
- A Lyme disease patient advocate to be invited to participate on the CACLD.
- More information regarding borreliosis in Australia is required in order to understand the requirements to resolve issues detailed in the committee’s terms of reference. Each member of the committee will be contacted out of session to discuss issues arising about borreliosis in Australia, which will assist the development of a discussion paper on Lyme borreliosis.
- Research requirements for borreliosis in Australia to be addressed at the next CACLD meeting.
The Committee met on 28 May 2013 with the following outcomes:
- Terms of Reference to be re-drafted to incorporate members' comments (endorsed terms of reference above).
- The Committee noted the outcomes of the committee consultations (outcome 3 from previous meeting) on:
- the existence of Lyme disease in Australia
- the members' perspective on the diagnostic pathway for Lyme disease in Australia
- the members' perspective on treatment options for Lyme disease in Australia.
The Committee met on 3 September 2013 with the following outcomes:
- Members were provided with an update on the progress of the scoping study being conducted to identify the research needs for an investigation into whether a causative tick-borne microorganism for Lyme disease exists in Australia.
- Members received an update on current research being conducted on ticks at the Murdoch University and potential collaborations and assistance was discussed.
- Members discussed a diagnostic pathway in the context of recent publications comparing North American and European testing approaches. Members agreed to continue this discussion out of session.
A summary of the committee consultations (outcome 3 from Meeting 1) titled CACLD Discussion Paper on Lyme Disease can be accessed below.
The Scoping study to develop a research project(s) to investigate the presence or absence of Lyme disease in Australia can be accessed below.
The Chief Medical Officer invites you to read the document and to provide comment on it to the department. Comments on the recommendations and which recommendations should have higher priority would be appreciated. The comments will be discussed at the next Clinical Advisory Committee on Lyme disease meeting in early 2014.
Please provide written comments marked "Attention Dr Gary Lum" to CACLD (CACLD@health.gov.au). The comments can be in the form of a simple e-mail or as attached annotations in tracked changes for Microsoft Word or as annotation notes for Adobe Acrobat. When making comments about specific sections please quote the page number and the paragraph referred to.
The closing date for comments is 31 January 2014.
When accessing large documents (over 500 KB in size), it is recommended that the following procedure be used:
- Click the link with the RIGHT mouse button
- Choose "Save Target As.../Save Link As..." depending on your browser
- Select an appropriate folder on a local drive to place the downloaded file
Attempting to open large documents within the browser window (by left-clicking)
may inhibit your ability to continue browsing while the document is
opening and/or lead to system problems.
To view PDF (Portable Document Format) documents, you will need to have a PDF reader installed on your computer. A number of PDF readers are available through the Australian Government Information Management Office (AGIMO) Web Guide website.